THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT Between Senetek PLC and Frank J. MassinoEmployment Agreement • March 25th, 2005 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 25th, 2005 Company Industry JurisdictionThis Third Amended and Restated Employment Agreement (“Agreement”) is made and entered into as of January 1, 2003 (the “Effective Date”), between Senetek PLC, a company organized under the laws of England (the ‘Company”) and Frank J. Massino (the “Executive”), residing at ***.
LICENSE AGREEMENTLicense Agreement • March 25th, 2005 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
Contract Type FiledMarch 25th, 2005 Company IndustryThis License Agreement (this “Agreement”) is made and entered into as December 2, 2004, by and between Senetek PLC, a company formed under English law with its registered office at 3 Howard Road, Eaton Socon, St Neots, Cambridgeshire, PE19 3ET, England and with its corporate headquarters located at 620 Airpark Road, Napa, California 94558 (“Senetek”), and Ferrosan A/S, a company formed under the laws of Denmark with its corporate headquarters located at Sydmarken 5, 2860 Soeborg, Denmark (“Licensee”).
Carme Cosmeceutical Sciences, Inc. Napa, California 94558 FORBEARANCE LETTER AGREEMENT November 8, 2004Forbearance Letter Agreement • March 25th, 2005 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledMarch 25th, 2005 Company Industry JurisdictionThis letter agreement (“Agreement”) is intended to set forth the terms upon which Carme Cosmeceutical Sciences, Inc., a Delaware corporation (“Lender”), the current holder of the loan described below (the “Loan”), will agree to forbear from enforcing rights to which Lender is entitled due to the current defaults under the Loan.
SENETEK PLCSenetek PLC /Eng/ • March 25th, 2005 • Biological products, (no disgnostic substances) • England
Company FiledMarch 25th, 2005 Industry JurisdictionUPON the Claimant and the Defendant having agreed terms of settlement of the action set forth in the schedule hereto and pursuant to Part 40.6 of the CPR.